No increased CV risk with systemic psoriasis therapies?

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2011年 / 1367卷 / 1期

关键词：

Psoriasis; Infliximab; Etanercept; Adalimumab; Plaque Psoriasis;

D O I：

10.2165/00128415-201113670-00006

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：3 / 3

相关论文

共 50 条

[1] NEW SYSTEMIC THERAPIES FOR PSORIASIS
WEBER, G
FREY, H
NEUGEBAUER, D
HAUTARZT, 1985, 36 (01): : 20 - 24
[2] New Systemic Therapies for Psoriasis
Mansouri, Yasaman
Goldenberg, Gary
CUTIS, 2015, 95 (03): : 155 - 160
[3] No increased Risk of severe Infections under Biologic Therapies in Patients with Psoriasis
Sossau, D.
Yazdi, A. S.
HAUTARZT, 2018, 69 (07): : 609 - 610
[4] Novel systemic therapies for the treatment of psoriasis
Tan, Ki-Wei
Griffiths, Christopher E. M.
EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (01) : 79 - 92
[5] PATHOMECHANISMS AND NEW SYSTEMIC THERAPIES IN PSORIASIS
WEBER, G
ACTA DERMATO-VENEREOLOGICA, 1984, : 147 - 149
[6] THE RISK OF KC IN PSORIASIS PATIENTS RECEIVING BIOLOGICS COMPARED TO CONVENTIONAL SYSTEMIC THERAPIES
Mason, Kayleigh
ACTA DERMATO-VENEREOLOGICA, 2018, 98 : 33 - 33
[7] Acceptable risk of therapies for psoriasis
Margolis, D
Filip, J
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 122 (03) : A59 - A59
[8] Systemic therapies for psoriasis: Understanding current and newly emerging therapies
Sobell, JM
Hallas, SJ
SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 2003, 22 (03) : 187 - 195
[9] Combining Traditional Systemic and Biologic Therapies for Psoriasis
Heffernan, Michael P.
SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 2010, 29 (01) : 67 - 69
[10] Current and Future Oral Systemic Therapies for Psoriasis
Kelly, John B., III
Foley, Peter
Strober, Bruce E.
DERMATOLOGIC CLINICS, 2015, 33 (01) : 91 - +

← 1 2 3 4 5 →